Cornerstone Planning Group LLC Merrimack Pharmaceuticals Inc Transaction History
Cornerstone Planning Group LLC
- $378 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding MACK
# of Institutions
2Shares Held
349Call Options Held
0Put Options Held
0About MERRIMACK PHARMACEUTICALS INC
- Ticker MACK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,410,200
- Market Cap $203M
- Description
- Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.